Encora Therapeutics

Encora Therapeutics develops non-invasive wearable technology for adults with essential tremor. Its FDA-cleared Encora X1 is a prescription wrist-worn device that uses mechanical neurostimulation to help relieve hand tremors in the treated limb during stimulation. Designed to support fine motor control throughout the day, it can be used without medication or alongside a person’s existing treatment plan, in consultation with a healthcare provider. The device is not a cure, and individual results may vary.

Encora X1 was designed at MIT and is manufactured in the United States. The company provides information about the device, its science, eligibility, and prescribing and ordering for physicians and VA providers. Patients can join a waitlist to receive guidance when the device is ready, including help with fit, coverage, and discussing it with a doctor. Encora also offers patient advocate support for navigating coverage, onboarding, and ongoing use. Its website includes resources for caregivers and healthcare providers, answers common questions, and shares clinical evidence and updates about the product.